Delivering Innovative Therapeutic Options for Gastrointestinal Diseases and Women’s Health

Sebela Pharmaceuticals® is a U.S. pharmaceutical
company with a market-leading position in Gastroenterology
and a focus on innovation in Women's Health.

MISSION, VISION, AND VALUES >

Sebela Pharmaceuticals® Announces Positive Topline Results from Phase 3 TRIUMpH Program of Tegoprazan in GERD

READ THE PRESS RELEASE >

The First Low-Dose Hormone-Free Intra-Uterine Device (IUD) in the U.S. in Over 40 Years

READ THE PRESS RELEASE >
MORE NEWS AND EVENTS >
RESEARCH AND DEVELOPMENT

RESEARCH AND DEVELOPMENT

The development strategy of Sebela Pharmaceuticals® aims to advance the company’s mission of improving patients’ lives with innovative pharmaceuticals. Through our affiliate Braintree, Sebela is leading the way in Gastroenterology.

LEARN MORE >

Corporate Partnership

Braintree, a part of Sebela Pharmaceuticals®, is a proud supporter of the following organizations:

Tablets
Tablets
Tablets
Tablets

DISCOVER SEBELA WOMEN’S HEALTH

Sebela Women’s Health seeks to enrich the health and well-being of women – and the lives of those who care about them. We're developing next-generation therapeutics with innovative features that help address the needs of women today.

DISCOVER MORE ABOUT US >
DISCOVER SEBELA WOMEN'S HEALTH